Standard name |
RADAEVA_RESPONSE_TO_IFNA1_DN |
Systematic name |
M19208 |
Brief description |
Genes down-regulated in primary hepatocytes and Hep3B (hepatocyte) cells in response to IFNA [GeneID=3439]. |
Full description or abstract |
BACKGROUND & AIMS: Interferon (IFN)-alpha therapy is currently the primary choice for viral hepatitis and a promising treatment for hepatocellular carcinoma (HCC). Primary mouse and rat hepatocytes respond poorly to IFN-alpha stimulation. Thus, it is very important to examine the IFN-alpha signal pathway in primary human hepatocytes. METHODS: The IFN-alpha-activated signals and genes in primary human hepatocytes and hepatoma cells were examined by Western blotting and microarray analyses. RESULTS: Primary human hepatocytes respond very well to IFN-alpha stimulation as shown by activation of multiple signal transducer and activator of transcription factor (STAT) 1, 2, 3, 5, and multiple genes. The differential response to IFN-alpha stimulation in primary human and mouse hepatocytes may be caused by expression of predominant functional IFN-alpha receptor 2c (IFNAR2c) in primary human hepatocytes vs. expression of predominant inhibitory IFNAR2a in mouse hepatocytes. Microarray analyses of primary human hepatocytes show that IFN-alpha up-regulates about 44 genes by over 2-fold and down-regulates about 9 genes by 50%. The up-regulated genes include a variety of antiviral and tumor suppressors/proapoptotic genes. The down-regulated genes include c-myc and c-Met, the hepatocyte growth factor (HGF) receptor. Down-regulation of c-Met is caused by IFN-alpha suppression of the c-Met promoter through down-regulation of Sp1 binding and results in attenuation of HGF-induced signals and cell proliferation. CONCLUSIONS: IFN-alpha directly targets human hepatocytes, followed by activation of multiple STATs and regulation of a wide variety of genes, which may contribute to the antiviral and antitumor activities of IFN-alpha in human liver. |
Collection |
C2: Curated CGP: Chemical and Genetic Perturbations |
Source publication |
Pubmed 11910354 Authors: Radaeva S,Jaruga B,Hong F,Kim WH,Fan S,Cai H,Strom S,Liu Y,El-Assal O,Gao B |
Exact source |
Table 2 |
Related gene sets |
(show 1 additional gene sets from the source publication)
(show 66 gene sets from the same authors)
|
External links |
|
Filtered by similarity ?
|
|
Source species |
Homo sapiens |
Contributed by |
Yujin Hoshida (Broad Institute) |
Source platform or identifier namespace |
HUMAN_SEQ_ACCESSION |
Dataset references |
|
Download gene set |
format: grp | gmt | xml | json | TSV metadata |
Compute overlaps ? |
(show collections to investigate for overlap with this gene set)
|
Compendia expression profiles ? |
NG-CHM interactive heatmaps
(Please note that clustering takes a few seconds)
GTEx compendium
Human tissue compendium (Novartis)
Global Cancer Map (Broad Institute)
NCI-60 cell lines (National Cancer Institute)
Legacy heatmaps (PNG)
GTEx compendium
Human tissue compendium (Novartis)
Global Cancer Map (Broad Institute)
NCI-60 cell lines (National Cancer Institute)
|
Advanced query |
Further investigate
these 10 genes
|
Gene families ? |
Categorize these
10 genes by gene family
|
Show members |
(show 10 source identifiers mapped to 10 genes)
Source Id |
NCBI (Entrez) Gene Id |
Gene Symbol |
Gene Description |
AA410591 |
4233 |
MET |
MET proto-oncogene, receptor tyrosine kin... |
AB006622 |
283638 |
CEP170B |
centrosomal protein 170B [Source:HGNC Sym... |
AF068706 |
8906 |
AP1G2 |
adaptor related protein complex 1 subunit... |
K00650 |
2353 |
FOS |
Fos proto-oncogene, AP-1 transcription fa... |
L04731 |
4297 |
KMT2A |
lysine methyltransferase 2A [Source:HGNC ... |
M19720 |
4610 |
MYCL |
MYCL proto-oncogene, bHLH transcription f... |
U01156 |
2740 |
GLP1R |
glucagon like peptide 1 receptor [Source:... |
U53204 |
5339 |
PLEC |
plectin [Source:HGNC Symbol;Acc:HGNC:9069] |
X06182 |
3815 |
KIT |
KIT proto-oncogene, receptor tyrosine kin... |
X06374 |
5154 |
PDGFA |
platelet derived growth factor subunit A ... |
|
Version history |
|